Jayme Dahlin

Jayme Dahlin, MD, PhD, serves as Associate Director/Principal Scientist at Agios Pharmaceuticals, leading translational medicine efforts for various clinical studies ranging from Phase 1 to Phase III. Expertise includes clinical biomarker selection, assay development, clinical trial design, regulatory submissions, and supporting business development as a translational development expert. Previous roles include contributions as a Senior Scientist for pivotal Phase 3 studies and as a Translational Medicine Consultant at NCATS, focusing on antiviral and rare diseases. Jayme Dahlin has an extensive background in clinical pathology, having served as a Clinical and Chief Resident at Brigham and Women's Hospital, and possesses a strong research foundation with a PhD focused on molecular pharmacology and experimental therapeutics. Educational credentials include an MD and PhD from Mayo Clinic, as well as a BA in Chemistry from Carleton College.